Following publication, the authors contacted the Editorial Office to request the retraction of the cited article, stating that further analysis of phage vB-ApyS-JF1 sequencing data discovered contamination with Mammaliicoccus sciuri DNA instead of Trueperella pyogenes. The conclusions reported in the article are no longer supported by the analyses; therefore, the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers of Microbiology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
Summary
Keywords
phage therapy, Trueperella pyogenes, vB-ApyS-JF1, Bacteremia, Mice
Citation
Frontiers Editorial Office (2023) Retraction: vB-ApyS-JF1, the first Trueperella pyogenes phage, shows potential as an alternative treatment strategy for Trueperella pyogenes infections. Front. Microbiol. 14:1334746. doi: 10.3389/fmicb.2023.1334746
Received
07 November 2023
Accepted
29 November 2023
Published
01 December 2023
Approved by
Rustam Aminov, University of Aberdeen, United Kingdom
Volume
14 - 2023
Updates
Copyright
© 2023 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.